Whole-Cell and Acellular Pertussis Vaccines: A Narrative Review of Biological, Clinical, Safety and Programmatic Evidence, with Implications for Poland
Andrzej Fal, Iwona Paradowska-Stankiewicz, Aneta Nitsch-Osuch, Ernest Kuchar · 2026
Read Whole-Cell and Acellular Pertussis Vaccines: A Narrative Review of Biological, Clinical, Safety and Programmatic Evidence, with Implications for Poland by Andrzej Fal, Iwona Paradowska-Stankiewicz, Aneta Nitsch-Osuch, Ernest Kuchar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611526.txt.
Description
Andrzej Fal and co-authors compare the two kinds of whooping cough vaccine in this 2026 review. One kind uses whole killed bacteria, the other uses a few purified parts. Poland is the only country in its region still starting babies on the whole-cell kind, which makes its record a useful test case.
The review weighs lab, clinic, safety, and program evidence from world and European sources. Whole-cell priming leaves a deeper, longer immune imprint but causes more sore arms and fevers. The purified kind is gentler but its shield fades within years. Neither stops the germ from settling in the nose. Eight peer countries using the purified kind reported more cases in 2024 than Poland did.
Catalog record
| CREATOR | Andrzej Fal, Iwona Paradowska-Stankiewicz, Aneta Nitsch-Osuch, Ernest Kuchar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |